EU regulators begin fast review of dexamethasone for COVID-19European regulators have begun a speedy review of dexamethasone as a treatment for adults hospitalised with COVID-19, a Share XEU regulators begin fast review of dexamethasone for COVID-19https://pharmaphorum.com/news/eu-regulators-begin-review-of-dexamethasone-for-covid-19/
US advisors add steroids to COVID-19 drug recommendationsThe Infectious Diseases Society of America (IDSA) says generic steroids should be used to treat patients hospitalised with Share XUS advisors add steroids to COVID-19 drug recommendationshttps://pharmaphorum.com/news/us-advisors-add-steroids-to-covid-19-drug-recommendations/
‘Major breakthrough’ as cheap steroid cuts deaths in COVID-19 patientsThe answer to improving survival rates in people with severe respiratory complications caused by COVID-19 is a generic Share X‘Major breakthrough’ as cheap steroid cuts deaths in COVID-19 patientshttps://pharmaphorum.com/news/major-breakthrough-as-cheap-steroid-cuts-deaths-in-covid-19-patients/
NICE backs interim funding for J&J/Takeda myeloma regimenA three-drug regimen for multiple myeloma based on Johnson & Johnson’s Darzalex, Takeda’s Velcade and dexamethasone will be Share XNICE backs interim funding for J&J/Takeda myeloma regimenhttps://pharmaphorum.com/news/nice-backs-interim-funding-for-jj-takeda-myeloma-regimen/
